Karuna Therapeutics is a biopharmaceutical company that develops treatments for psychiatric and neurological conditions. Karuna Therapeutics creates drugs that can significantly improve the lives of people who suffer from neurological and psychiatric illnesses, with a particular focus on schizophrenia and the behavioral symptoms of Alzheimer's disease. The company is skilled in neuroscience and has creative ideas for finding and developing new drugs. Karuna Therapeutics is advancing a pipeline of innovative drugs since its inception with the aim of significantly improving the lives of people suffering from these difficult conditions.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
339
Frequently Asked Questions
What is Market Cap of Karuna Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Karuna Therapeutics Inc market cap is $12.6B.
What is the 52-week high for Karuna Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Karuna Therapeutics Inc 52 week high is $329.99 as of September 28, 2025.
What is the 52-week low for Karuna Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Karuna Therapeutics Inc 52 week low is $158.38 as of September 28, 2025.
What is Karuna Therapeutics Inc stock price today?
Karuna Therapeutics Inc stock price today is $329.83.
What was Karuna Therapeutics Inc stock price yesterday?
Karuna Therapeutics Inc stock price yesterday was $329.74.
What is the PE ratio of Karuna Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Karuna Therapeutics Inc’s P/E ratio is -28.13.
What is the Price-to-Book ratio of Karuna Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Karuna Therapeutics Inc P/B ratio is 10.0134.
What is Karuna Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Karuna Therapeutics Inc's EBITDA is -21.73.
What is the 50-day moving average of Karuna Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Karuna Therapeutics Inc 50-day moving average is $319.50.
How many employess does Karuna Therapeutics Inc has?
